Panbio Nasopharyngeal Test

COVID-19 Ag Rapid Test Device

Abstract

Several rapid testing methodologies have been approved for testing of symptomatic individuals but have not been validated for asymptomatic screening. We evaluated performance of the Abbott PanbioTM COVID-19 rapid antigen assay in the asymptomatic setting. We conducted a prospective study in an urban assessment center and in the context of long-term care staff screening. A total of 3014 individuals submitted paired nasopharyngeal samples, which were tested in parallel with the rapid antigen and laboratory-based, RT-PCR assays SARS-CoV-2 detection. There was 54.5% concordance in positive results between the rapid antigen assay and RT-PCR. All positive rapid antigen assay results were confirmed by RT-PCR. The negative predictive value of the rapid antigen assay minimally improved on the negative pre-test probability of SARS-CoV-2 infection. The Abbott PanbioTM COVID-19 rapid antigen test allowed for faster identification of infected individuals but cannot be used to rule-out SARS-CoV-2 infection.

Keywords: Asymptomatic screening; Covid-19; Laboratory oversight; Point of care testing; Quality assurance; Rapid antigen.

MARK antibody
Fitzgerald
MARK antibody
Fitzgerald
MARK Antibody
SAB
MARK Antibody
SAB
MARK Antibody
Lifescience Market

Conflict of interest statement

Declaration of Competing Interests The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper. J. Shaw has served as an Advisory Board Member for Abbott.

Self-Tests enable fast testing and reporting to help curb the spread of infection 

The Panbio COVID-19 Antigen Self-Test is easy-to-use, and people can take the test by using a simple nasal swab (not the deep nasopharyngeal swab) while following the Instructions for Use steps on pack. For children younger than 14 years, an adult caretaker should help collect the nasal samples and conduct the test procedures.  The kit contains all the materials required including nasal swabs, test devices and reagent ampules. No additional instrumentation is required to conduct the test.

Self-test kits are offered in packages of one, four, 10 and 20 tests. With results in just 15 minutes, the Panbio COVID-19 Antigen Self-Test enables people who test positive to immediately isolate so that they do not infect others, rather than waiting days for results.

Recombinant Humanp21 Recombinant Protein
ProSci
Recombinant phosphopantetheine adenylyltransferase (PPAT) (Recombinant)
Abbexa
Glyco Recombinant Protein A33 Recombinant Protein
ProSci
Glyco Recombinant Protein A33 Recombinant Protein
ProSci
STAG3L1 Recombinant Protein (Human) (Recombinant Tag)
ABM

See More- maxanim.com

The test is to be used along with Abbott’s NAVICA mobile app, available in the Google Play and Apple app store. The app offers a simple and streamlined process of self-registration, automatic reading of results and easy reporting as per ICMR guidelines. Panbio Self-Tests will be available via retail pharmacies and through e-commerce platforms, as well as through organizations and institutions.

 

Panbio Nasopharyngeal Test
Panbio Nasopharyngeal Test

Rapid point of care testing delivers timely health information to inform treatment

Abbott has multiple professional use diagnostic test options in India that deliver reliable, on-the-spot results. Abbott offers the Panbio COVID-19 Ag Rapid Test Device for professional use. This version of the test – which is scientifically identical to the self-test– can be administered by health professionals on adults and children, with or without symptoms. Like the Panbio Self-Test, the professional test offers a minimally invasive nasal swab option for the assisted, supervised sample collection, which can help people who are not comfortable with the deep nasopharyngeal swab. It delivers results in 15 minutes.

The Panbio professional test demonstrated 95.7% sensitivity and 97.6% specificity when benchmarked against RT-PCR tests, indicating high reliability.i Abbott is the only diagnostics manufacturer to provide performance data on a rapid antigen test specific for use on children who are 15 years and younger, including infants. Panbio has CE Mark for asymptomatic use and supervised nasal swab collection and is on the World Health Organization (WHO) Emergency Use Listing.

Recombinant Humanp21 Recombinant Protein
92-035
Recombinant phosphopantetheine adenylyltransferase (PPAT) (Recombinant)
20-abx072018
Glyco Recombinant Protein A33 Recombinant Protein
96-361
Glyco Recombinant Protein A33 Recombinant Protein
96-364
STAG3L1 Recombinant Protein (Human) (Recombinant Tag)
RP030283

Since last August to date, Abbott has shipped 300 million Panbio COVID-19 Antigen Rapid tests for professional use in more than 100 countries across Europe, the Americas, Asia and Africa.

Also available is Abbott’s ID NOW system, a molecular point-of-care test the size of a toaster that’s designed to deliver results in less than 15 minutes. ID NOW is being widely being used at airports, emergency departments, diagnostics laboratories and in a wide variety of other point-of-care settings.

For more information on Abbott’s Rapid Diagnostics portfolio in India

About Abbott

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 109,000 colleagues serve people in more than 160 countries.

CD11b Antibody Antibody
ABD2911
ASAP1 antibody Antibody
DF8746
anti- Antibody^Polyclonal antibody control antibody
LSMab09882
Antibody
A1360-500
Anti-Glycolipid Antibody (AGA) Antibody
20-abx004855

Abbott Launches Panbio COVID-19 Antigen Self-Test in India; Strengthens Rapid Diagnostics Portfolio to Support Testing Needs at Home, Work and at Clinics

  • Panbio COVID-19 Antigen Self-Test has received CE Mark for over-the-counter use in adults and children, with or without symptoms
  • The self-test features a minimally invasive nasal swab and delivers results in as early as 15 minutes with no instrumentation, using proven Abbott lateral flow technology
  • Automatic reading of test results and fast, easy online reporting to Indian Council of Medical Research (ICMR) via Abbott’s NAVICA reporting app
  • In clinical evaluations with self-test users, the Panbio Self-Test correctly identified 95.2% of positive samples and 100% of negative samples

 

 

MUMBAI, July 12, 2021 —Abbott has announced the launch of Panbio™ COVID-19 Antigen Self-Test for the detection of the SARS-CoV-2 virus in adults and children with or without symptoms. In alignment with the current ICMR advisory on self-use, these tests will be made available to ramp up testing of symptomatic and asymptomatic individuals and contacts of confirmed coronavirus cases.

CD11b Antibody Antibody
ASAP1 antibody Antibody

Abbott will deliver millions of Panbio COVID-19 Rapid Antigen Tests available for self-use to ease the burden on healthcare systems in urban and rural India. Since the tests provide critical information at a point in the infection cycle when people are at the highest risk of spreading the disease, they can be a powerful tool to slow the spread of infection.

“India needs a clear, multi-pronged COVID-19 response strategy,” said Professor Nirmal Kumar Ganguly, former Director General, ICMR. “Scaling access to easy, accurate and fast testing can speed up the country’s preparedness and curb community contagion. Self-testing at home empowers individuals with the ability to carry out the first line of protection against disease transmission. This not only streamlines the process of isolation, tracing and tracking but also supports people in taking charge of their own health and enhances participation of individuals willingly.”

In India, Abbott will offer self-tests for use at home, assisted professional testing at point of care and laboratories, as well as workplace testing to help enable a sense of normalcy in returning to places of employment.

“Rapid antigen testing is critical in the fight against COVID-19 and Abbott is delivering a variety of diagnostics options at a critical juncture in the pandemic,” said Sanjeev Johar, divisional vice president of Abbott’s rapid diagnostics business in Asia Pacific. “Self-testing is a proven tool that provides an added layer of defense along with public health protocols and the vaccine roll out.”

Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
ELISA-1
Beta2-Microglobulin ELISA kit ELISA Kit
LF-EK60047
Chicken thrombomodulin,TM ELISA KIT ELISA
QY-E80092

Self-Tests enable fast testing and reporting to help curb the spread of infection 

The Panbio COVID-19 Antigen Self-Test is easy-to-use, and people can take the test by using a simple nasal swab (not the deep nasopharyngeal swab) while following the Instructions for Use steps on pack. For children younger than 14 years, an adult caretaker should help collect the nasal samples and conduct the test procedures.  The kit contains all the materials required including nasal swabs, test devices and reagent ampules. No additional instrumentation is required to conduct the test.

Self-test kits are offered in packages of one, four, 10 and 20 tests. With results in just 15 minutes, the Panbio COVID-19 Antigen Self-Test enables people who test positive to immediately isolate so that they do not infect others, rather than waiting days for results.

The test is to be used along with Abbott’s NAVICA mobile app, available in the Google Play and Apple app store. The app offers a simple and streamlined process of self-registration, automatic reading of results and easy reporting as per ICMR guidelines. Panbio Self-Tests will be available via retail pharmacies and through e-commerce platforms, as well as through organizations and institutions.

Custom Antibody titration by ELISA up to 2 rabbits and 1 bleed
Alpha Diagnostics
Beta2-Microglobulin ELISA kit ELISA Kit
Abfrontier
Chicken thrombomodulin,TM ELISA KIT ELISA
Qayee Biotechnology

Sources

1. Labnet
2. Gentaur
3. Fortislife
4. What is paraffin wax?

Leave a Reply

Your email address will not be published. Required fields are marked *